Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
| Cat. No. | Species | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|
| GTF-H5253 | Human | Human CTGF / CCN2 Protein, Fc Tag |  |
|
|
| GTF-R52H4 | Rhesus macaque | Rhesus macaque CTGF / CCN2 Protein, His Tag |  |
|
|
| CTF-M52Hc | Mouse | Mouse CTGF / CCN2 Protein, His Tag |  |
|
|
| CTF-H52H5 | Human | Human CTGF / CCN2 Protein, His Tag |  |
|
|
| CTF-H82E6 | Human | Biotinylated Human CTGF / CCN2 Protein, His,Avitag™ (recommended for biopanning) |  |
|
|
Loaded Monoclonal Anti-Human CTGF Antibody, Human IgG1 on AHC Biosensor, can bind Mouse CTGF, His Tag (Cat. No. CTF-M52Hc) with an affinity constant of 2.46 nM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).
| Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
|---|---|---|---|---|---|---|---|---|---|---|
| Penicillamine | Approved | Valeant | Distamine, Pemine, Trisorcin, Cuprimine, Cupramine, Trolovol | Mainland China | Hepatolenticular Degeneration; Lead Poisoning; Arthritis, Rheumatoid; Heavy Metal Poisoning | Sichuan Pharmaceutical Co Ltd | 1970-12-04 | Heavy Metal Poisoning; Arthritis, Rheumatoid; Hepatolenticular Degeneration; Cystinuria; Lead Poisoning | Details |
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| SHR-1906 | SHR-1906 | Phase 1 Clinical | Guangdong Hengrui Pharmaceutical Co Ltd | Idiopathic Pulmonary Fibrosis | Details |
| RXI-109 | RXI-109 | Rxi Pharmaceutical | Details | ||
| EXC-001 | EXC-001; PF-6473871; PF-06473871 | Ionis Pharmaceuticals Inc | Details | ||
| LEM-S401 | LEM-S401; LEMS401 | Phase 1 Clinical | Lemonex Inc | Cicatrix | Details |
| PRS-220 | PRS-220 | Phase 1 Clinical | Pieris Pharmaceuticals | Idiopathic Pulmonary Fibrosis | Details |
| Pamrevlumab | FG-3019 | Phase 3 Clinical | Fibrogen Inc | Diabetes Mellitus, Type 2; Idiopathic Pulmonary Fibrosis; Pancreatic Neoplasms; Coronavirus Disease 2019 (COVID-19); Liver Cirrhosis; Glomerulosclerosis, Focal Segmental; Muscular Dystrophy, Duchenne; Diabetic Nephropathies; Diabetes Mellitus | Details |
| OLX-10010 | cp-asiCTGF; OLX-101A; OLX-10010; BMT-101; OLX-101 | Phase 2 Clinical | Olix Pharmaceuticals Inc | Pulmonary Fibrosis; Wet Macular Degeneration; Macular Degeneration; Cicatrix, Hypertrophic | Details |
This web search service is supported by Google Inc.
A-Z
